Page 9 - FLIPBOOK
P. 9
Improved 2 year overall survival in first line RCC
% of patients alive at 2 years
Date of FDA Approval or Publication
Motzer NEJM (COMPARZ) 2013, Escudier (AVOREN) JCO 2010,Tannir (CM214) GU ASCO 2019, Choueiri (CABOSUN) JCO 2017, Rini NEJM 2018, Motzer NEJM 2021
